NEU — Neuren Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSuper Stock

Annual balance sheet for Neuren Pharmaceuticals, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	24.2	36.8	40.2	229	222
Net Total Accounts Receivable
Net Total Receivables	0.755	1.42	1.09	14.4	175
Prepaid Expenses
Total Other Current Assets
Total Current Assets	24.9	40	43.2	247	399
Net Property, Plant And Equipment	0.01	0.012	0.021	0.043	0.031
Other Long Term Assets
Total Assets	25	40.1	43.3	248	410
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.753	0.803	1.68	42.8	45.8
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.753	0.803	1.68	42.8	45.8
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	24.2	39.3	41.6	205	364
Total Liabilities & Shareholders' Equity	25	40.1	43.3	248	410
Total Common Shares Outstanding